Skye Bioscience (SKYE) Assets (2012 - 2026)
Skye Bioscience (SKYE) recorded Assets of $11.03 million in Q2 2026, down 78.8% from $52.16 million a year earlier and down 43.2% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience reported Assets of $28.31 million, down 61.1% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 60.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $72.76 million in FY2024 (+509.4%), $11.94 million in FY2023 (+31.1%), $9.11 million in FY2022 (-7.5%) and $9.86 million in FY2021 (+268.9%).
- The Q2 2026 figure is the lowest quarterly Assets since Q2 2023.
- On a year-over-year basis, Assets has declined for six consecutive quarters, with growth averaging 75.1% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 509.4% in Q4 2024, against a decline of 78.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $19.42 million (Q1 2026), $28.31 million (Q4 2025) and $41.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 11.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.03 Mn |
| Mar 31, 2026 | 19.42 Mn |
| Dec 31, 2025 | 28.31 Mn |
| Sep 30, 2025 | 41.32 Mn |
| Jun 30, 2025 | 52.16 Mn |
| Mar 31, 2025 | 64.79 Mn |
| Dec 31, 2024 | 72.76 Mn |
| Sep 30, 2024 | 81.54 Mn |
| Jun 30, 2024 | 87.26 Mn |
| Mar 31, 2024 | 94.84 Mn |
| Dec 31, 2023 | 11.94 Mn |
| Sep 30, 2023 | 15.60 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Sep 30, 2022 | 2.87 Mn |
| Jun 30, 2022 | 4.97 Mn |
| Mar 31, 2022 | 7.21 Mn |
| Dec 31, 2021 | 9.86 Mn |
| Sep 30, 2021 | 11.69 Mn |
API Access
Skye Bioscience Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();